The diagnosis of acute myocardial infarction (AMI) in the elderly is difficult and often depends on the results of investigations. In a 3-month prospective study, 270 patients admitted to an acute geriatric unit were studied to determine the most effective diagnostic strategy for the diagnosis ofAMI, and to assess the value of screening acute geriatric admissions for AMI.
Introduction
Acute myocardial infarction (AMI) is a common cause for hospital admission to acute geriatric units. The diagnosis of AMI is difficult,' and especially in the elderly who may present silently or with non-specific clinical features.2'3 In addition, the prognosis ofAMI worsens with increasing age. 4 These factors have led to the suggestion that ill elderly patients should be screened for AMI. 3 There is no consensus on biochemical tests nor on numbers of electrocardiograms (ECG) required in the diagnosis of AMI. The choice of biochemical test(s) and how often they should be measured varies not only between but also within countries.'-'
The aims of this prospective study were firstly to optimize a strategy of serial electrocardiograms (ECG) and serial measurements of creatine kinase (CK), aspartate aminotransferase (AST) and lactate dehydrogenase (LDH) activities in the investigation of AMI in the elderly, and secondly to assess the value of screening acute geriatric admissions for AMI.
Methods and materials
All patients admitted to the acute geriatric unit between May 
Discussion
In view of the severity of AMI in the elderly, optimum sensitivity (no AMIs missed) is more important than specificity (fewest false positives) or efficiency (% of results which are correct). In this study, measurement of serum CK and AST on the first two days of admission had a sensitivity of 100% and specificity of 86.8% for the diagnosis of a Definite AMI. This was the best combination of cardiac enzymes to achieve maximum sensitivity with the minimum number of tests. The sensitivity of ECGs for the diagnosis ofAMI was low when compared to biochemical tests. The value of the ECG was its high predictive value for a positive result, that is a diagnostic ECG was always due to a Definite AMI. In contrast, although 'cardiac enzymes' are considered to be diagnostic tests a significant proportion (15%) of cases who did not have a Definite or Possible AMI had 'diagnostically' elevated cardiac enzyme activities. Care must, therefore, be taken in attributing elevated cardiac enzyme activity to myocardial injury when there is little clinical or ECG evidence to support this.
In this unit, ECGs and measurement of serum CK and AST activities on the first two days of admission has replaced our previous strategy of serial ECGs and measuring serum CK, AST and LDH activities on the first three days of admission.
What are the net savings in reducing the number of biochemistry tests from 9 to 4 and ECGs from 3 to 2? Laboratory revenue costs may be divided into those which are fixed and independent of workload and those which are variable and directly proportional to the numbers of tests done.'0 The net savings in changing strategies will, therefore, be those of consumable costs (variable expenditure) equivalent to only £0.87 per patient.
In this study 9% of patients had a Definite AMI and 6% a Possible AMI. Over half the presentations of Definite AMI were atypical. The physicians were aware of this in that AMI was considered a possibility in one third of admissions. This awareness and absence of silent AMIs suggests that screening all geriatric admissions is not justified and that investigation should be guided by clinical factors. Furthermore, screening all admissions with ECGs and measurement of serum CK and AST activities on the first two days of admission would unnecessarily cost (variable expenditure) an extra £987 per annum.
Although the cost savings are small there are other important benefits in reducing the number of unnecessary tests. Fewer false positive results would be expected to lead to a reduction in further perhaps unnecessary investigations. One less venepuncture for the patient and more rapid diagnosis represents an improvement in the quality of patient care. The time saved by the doctor, and the laboratory and ECG technicians could be redeployed to other areas of clinical or laboratory activity.
This study was undertaken not to evaluate new tests but to optimize our current diagnostic tools with the classical approach popularized by Galen and Gambino8 and it illustrates that increased diagnostic effectiveness, cost-effectiveness and improved patient care can be complementary.
